1. Home
  2. EPSN vs SPRO Comparison

EPSN vs SPRO Comparison

Compare EPSN & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$5.63

Market Cap

187.2M

Sector

Energy

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.83

Market Cap

156.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPSN
SPRO
Founded
2005
2013
Country
United States
United States
Employees
N/A
25
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.2M
156.3M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
EPSN
SPRO
Price
$5.63
$2.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
153.7K
861.4K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
4.01%
N/A
EPS Growth
N/A
111.81
EPS
0.02
N/A
Revenue
N/A
$66,802,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$300.00
P/E Ratio
$283.00
N/A
Revenue Growth
N/A
39.24
52 Week Low
$4.20
$1.80
52 Week High
$8.50
$3.09

Technical Indicators

Market Signals
Indicator
EPSN
SPRO
Relative Strength Index (RSI) 40.90 54.76
Support Level $5.57 $2.18
Resistance Level $5.91 $3.07
Average True Range (ATR) 0.21 0.18
MACD -0.02 -0.02
Stochastic Oscillator 5.22 57.50

Price Performance

Historical Comparison
EPSN
SPRO

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: